Navigation Links
Preterm Infants with Respiratory Distress Syndrome: Incidence Rates,of Death when Treated with Surfactant Replacement Therapies

ong RDS babies treated with poractant alfa at an initial dose of 200 mg/kg than with beractant. Results from this large database analysis are consistent with the findings of our trial and other similar trials comparing poractant alfa and beractant. Furthermore, these analyses also demonstrated statistically significant survival benefits with poractant alfa treatment when compared with the other two natural surfactants available for clinical use in the United States. These results suggest that neonatologists should carefully weigh their choice of surfactant therapy in their clinical practice."

The study presented today was supported by a research grant from Chiesi Farmaceutici of Parma, Italy, manufacturer of Curosurf(R) Intratracheal Suspension, and Dey, L.P., US marketer of Curosurf(R).

"We are pleased to have supported this study and are impressed with its results," said J. Melville Engle, President and Chief Executive Officer of Dey, L.P. "To the extent that these data will affect clinical practice, these outcomes bode well for the health of premature infants and the peace of mind of their families."

Paolo Chiesi, Vice President, R&D Director of Chiesi Farmaceutici, concurred: "Curosurf(R) is already the most widely used surfactant in the world, and we look forward to its being used to treat more babies suffering from RDS in the United States. We are delighted that this large data analysis so strongly validates the clinical value of Curosurf(R)."

About Curosurf(R)

Curosurf(R) Intratracheal Suspension is indicated for the treatment (rescue) of RDS in premature infants. Curosurf(R) reduces mortality and pneumothoraces associated with RDS.

Curosurf(R) Intratracheal Suspension compensates for the deficiency of surfactant in preterm infants with RDS and restores surface activity to the lungs of these infants. Because Curosurf(R) works rapidly, infants should receive frequent clinical and laboratory assessments so that oxyg
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
2. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
3. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
4. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
5. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
6. Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus
7. Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
8. DVT Awareness Survey Findings: Heart and Respiratory Patients
9. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
10. New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death
11. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
Post Your Comments:
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and specialty ... consumers, employers and government health plans $23.3 billion ... by the Pharmaceutical Care Management Association (PCMA). ... offers one of the easiest ways to reduce ... Mark Merritt . "Policymakers should resist efforts to ...
(Date:2/26/2015)... Research and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) ... Equipment - Global Strategic Business Report" report to ... worldwide markets for Radiation Therapy Equipment in US$ Million ... Systems, and Radiation Therapy Simulator. The report provides separate ... , Japan , Europe ...
(Date:2/26/2015)... 26, 2015 The report, ... washer, Filler, Capper, Blow molder, Shrink wrapper), Technology ... Flavored, Sparkling) & Region - Trends & Forecasts ... the bottled water processing market with analyses and ... of value. It also identifies the driving and ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4
... Immucor, Inc. (Nasdaq: BLUD ), a global leader in providing automated ... generation automated instrument, NEO™, has been cleared for marketing in the U.S. ... blood bank instrument designed to meet the needs of high volume laboratories. ... "We believe there is ...
... April 30 A new study, presented at the American Society ... Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of ... , , ... in several other studies to improve breast cancer detection and aid in ...
Cached Medicine Technology:Immucor Announces FDA Clearance of NEO, the Company's Fourth Generation Automated Instrument 2BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy 2
(Date:2/26/2015)... (PRWEB) February 26, 2015 Dr. Parsa Mohebi, ... his hair transplant contest winner’s surgery on Friday, ... winner Marc R., is all set to receive his grand ... ARTAS system. His procedure will be done on a live ... To watch the surgery, go to the website and experience ...
(Date:2/26/2015)... Chicago, IL (PRWEB) February 26, 2015 ... a small step to fund powerful progress for the ... season by raising critical funds and awareness that will ... adults fighting muscle disease. , “MDA Muscle Walk events ... progress for people whose abilities to move are compromised ...
(Date:2/26/2015)... PartnerTech Inc . has announced it has ... finalist. , The Movers & Makers Awards are ... processing, or distribution of tangible products and will be held ... event serves as Georgia’s largest local awards ceremony for manufacturing ... than 300 local industry and business leaders. , “We ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The COR ... Topical BioMedics, Inc., Rhinebeck, NY, to offer customers a ... topical biomedicine formulas that safely and effectively address muscle, ... new division of Vets Access LLC, Montrose, MI, that ... healing products. , Topical BioMedics is a research and ...
(Date:2/26/2015)... In a nested-case control study of individuals living in the ... incidence of liver cancer, statin use is associated with a ... study published February 26 in the JNCI: Journal of ... this association but most used data from individuals living in ... Asia. Katherine A. McGlynn, Ph.D., from the Division of Cancer ...
Breaking Medicine News(10 mins):Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3
... in the USA from recycled plastic bottles, the new Airnamic Green ... effectively removes dust, pet dander, grass and tree pollen, mold spores ... of plastic drink bottles provides consumers with an anti-microbial, moisture resistant, ... , ...
... magazine providing news and commentaries on issues that affect the ... workplace for an audience of predominantly African-American professionals, corporate executives ... Black Women in Business." , ... ...
... their newest hair loss video diaries and hair growth comparisons. The results ... video. , ... London, UK (PRWEB) February 11, 2009 -- For six ... user with video diaries. Diya Lababidi has been using one of Belgravia,s ...
... 10 Nationwide Health Properties, Inc. (NYSE: NHP ... M. Pasquale as Chairman of the Board and Robert D. ... Mr. Paulson are currently directors. These appointments will take ... Mr. Pasquale will succeed Charles D. Miller, who will remain ...
... Feb. 10 Mesa Laboratories, Inc. (Nasdaq: MLAB ) today reported significantly ... December 31, 2008. Highlights: , , , ... Third quarter net income increases 8% , ... , , For the third quarter of fiscal ...
... Feb. 10 Hanger Orthopedic Group, Inc. (NYSE: ... quarter ended December 31, 2008, an increase of $14.7 million, ... quarter. Pre-tax income increased $3.0 million, or 29.8%, to ... in the same quarter last year.Pro forma net income applicable ...
Cached Medicine News:Health News:Can a New Green Product Made From Recycled Plastic Soda Bottles Provide Cleaner Indoor Air and a Healthier Home? 2Health News:The Network Journal Announces it's 2009 List of "25 Influential Black Women in Business" 2Health News:The Network Journal Announces it's 2009 List of "25 Influential Black Women in Business" 3Health News:Best Hair Loss Treatment Results Ever Captured on Video? 2Health News:Best Hair Loss Treatment Results Ever Captured on Video? 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 9Health News:Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008 10
... The PowerEase® 500 Power ... mini-gel electrophoresis. It offers extensive ... and four custom methods for ... own preferences. The simple, intuitive ...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
EPS 3501 : 3500 V, 150 mA, 100 W maximum. Constant voltage, constant current, or constant power modes. Stores and recalls three protocols. Excellent for manual DNA sequencing and IEF applications....
... supply, with temperature probe, 100-120 and 220-240 V, ... mA, and 400 W. The temperature probe is ... 90 degrees C during electrophoresis. Built-in infrared capability ... instructions are provided. Dimensions are 27.5 x 34 ...
Medicine Products: